StemBioSys Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:StemBioSys Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11251
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates natural environment and replicates a 3-dimensional microenvironment which allows stem cells more rapidly with greater preservation of stem cell phenotype than traditional ones. The company’s target therapy areas include diabetes, Parkinson’s disease, Alzheimer’s disease, osteoarthritis, inflammatory disorders and damaged cartilage. StemBioSys is headquartered in San Antonio, Texas, the US.

StemBioSys Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
StemBioSys Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
StemBioSys Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
StemBioSys Raises Additional USD1.4 Million in Series B Financing 10
StemBioSys Raises USD2.7 Million in Venture Financing 11
StemBioSys Raises USD8 Million in Series A Financing 12
StemBioSys Raises US$4.4 Million In Venture Financing 13
Partnerships 14
StemBioSys Enters into Distribution Agreement with SeouLin Bioscience 14
Gencure Enters into Agreement with StemBioSys 15
Cellular Dynamics Enters into Distribution Agreement with Seoulin Bioscience 16
StemBioSys Partners with Cardiovate 17
StemBioSys Inc – Key Competitors 18
StemBioSys Inc – Key Employees 19
StemBioSys Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Product News 21
Feb 28, 2018: New branding identity and expanded product line announced by StemBioSys 21
Other Significant Developments 22
Jan 18, 2017: StemBioSys Announces US and Canadian Distribution Agreement with VWR 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
StemBioSys Inc, Pharmaceuticals & Healthcare, Key Facts 2
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
StemBioSys Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
StemBioSys Inc, Deals By Therapy Area, 2012 to YTD 2018 8
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
StemBioSys Raises Additional USD1.4 Million in Series B Financing 10
StemBioSys Raises USD2.7 Million in Venture Financing 11
StemBioSys Raises USD8 Million in Series A Financing 12
StemBioSys Raises US$4.4 Million In Venture Financing 13
StemBioSys Enters into Distribution Agreement with SeouLin Bioscience 14
Gencure Enters into Agreement with StemBioSys 15
Cellular Dynamics Enters into Distribution Agreement with Seoulin Bioscience 16
StemBioSys Partners with Cardiovate 17
StemBioSys Inc, Key Competitors 18
StemBioSys Inc, Key Employees 19
StemBioSys Inc, Other Locations 20
StemBioSys Inc, Subsidiaries 20

List of Figures
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[StemBioSys Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3P Biopharmaceuticals SL-製薬・医療分野:企業M&A・提携分析
    Summary 3P Biopharmaceuticals SL (3P), a subsidiary of Infarco SA is a biotechnology company that offers biological and cell therapy products. The company offers biologic services such as cell-banks, process development, GMP manufacturing and analytical QC services. Its cell therapy services compris …
  • VentriPoint Inc:製品パイプライン分析
    Summary VentriPoint Inc (VentriPoint), a subsidiary of VentriPoint Diagnostics Ltd is a medical device company that manufactures and distributes medical devices for the cardiovascular market. The company’s product VMS is a heart visualization system which is used to evaluate right heart function. It …
  • Medical Prognosis Institute AS (MPI)-医療機器分野:企業M&A・提携分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers DRP platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurpo …
  • Ferring International Center SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (foll …
  • Sappi Limited:企業の戦略・SWOT・財務分析
    Sappi Limited - Strategy, SWOT and Corporate Finance Report Summary Sappi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Qatar Shipping Co:企業の戦略的SWOT分析
    Qatar Shipping Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Extreme Networks, Inc. (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks, Inc. (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Chevron Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Chevron Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and di …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …
  • Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threat …
  • The Weir Group Plc (WEIR):電力:M&Aディール及び事業提携情報
    Summary The Weir Group Plc (Weir Group) is a provider of engineering solutions. The company designs and manufactures highly engineered products and services for minerals, oil and gas, and power industries. Its products and service portfolio include pressure pumping equipment, pressure control produc …
  • Aluar Aluminio Argentino SAIC:企業の戦略・SWOT・財務分析
    Aluar Aluminio Argentino SAIC - Strategy, SWOT and Corporate Finance Report Summary Aluar Aluminio Argentino SAIC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Philippine Long Distance Telephone Company:企業のM&A・事業提携・投資動向
    Philippine Long Distance Telephone Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Philippine Long Distance Telephone Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Just Group plc:戦略・SWOT・企業財務分析
    Just Group plc - Strategy, SWOT and Corporate Finance Report Summary Just Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Huaneng Power International, Inc.:企業の戦略・SWOT・財務情報
    Huaneng Power International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Huaneng Power International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • American Bio Medica Corp (ABMC):企業の財務・戦略的SWOT分析
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • B.L. Kashyap and Sons Ltd:企業の戦略・SWOT・財務情報
    B.L. Kashyap and Sons Ltd - Strategy, SWOT and Corporate Finance Report Summary B.L. Kashyap and Sons Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Novanta Inc (NOVT)-医療機器分野:企業M&A・提携分析
    Summary Novanta Inc (Novanta), formerly GSI Group Inc. is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam d …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512):企業の財務・戦略的SWOT分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company prov …
  • Laboratoires Thea SA:企業の戦略的SWOT分析
    Laboratoires Thea SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆